Decera Clinical Education Infectious Disease Podcast
Episodes
COVID-19 Update: Independent Conference Coverage of ECCMID 2023
05 May 2023
Contributed by Lukas
In this episode, Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI, discusses new data on COVID-19 presented at ECCMID 2023, including:Treatment in spe...
2023 Audio Recap: Principles of Outpatient COVID-19 Management
03 May 2023
Contributed by Lukas
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-...
Complicated Clinical Infections: Clinical Impact of New Data From ECCMID 2023
03 May 2023
Contributed by Lukas
In this episode, David van Duin, MD, PhD, FIDSA, FAST, discusses new data on complicated clinical infections presented at ECCMID 2023, including:Gram-...
2023 Audio Recap: Practical Case Studies in Outpatient COVID-19 Management
02 May 2023
Contributed by Lukas
In this episode, Tracey Piparo, PA-C, and Renslow Sherer, MD, discuss cases of nonhospitalized patients with COVID-19, including:Young, healthy patien...
Q&A: HDV Management Episode 2
26 Apr 2023
Contributed by Lukas
In this episode, Tatyana Kushner, MD, MSCE, and Stefan Zeuzem, MD, address key considerations when screening, diagnosing, and treating patients with H...
Overcoming HBV Barriers: Focus on Asian American People
25 Apr 2023
Contributed by Lukas
In this episode, Joseph Lim, MD; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and Jennifer Wild, MS, BSN, RN, OCN, discuss strategies for overcoming barri...
African Immigrant People: Overcoming HBV Barriers
25 Apr 2023
Contributed by Lukas
In this episode, Essa Mohamed, PhD; Daouda Ndiaye; and Ponni Perumalswami, MD, MS, discuss strategies for overcoming barriers to HBV care in African i...
Individualizing HIV ART: Considerations for Weight Gain
24 Apr 2023
Contributed by Lukas
In this episode, Daniel R. Kuritzkes, MD, discusses considerations for patients experiencing weight gain on antiretroviral therapy, including:• Comm...
Rapid ART Initiation: Answering the Questions
21 Apr 2023
Contributed by Lukas
In this episode, Isolde Butler, MD, and Brenda E. Crabtree Ramírez, MD, discuss rapid ART initiation for people newly diagnosed with HIV, including:T...
Individualizing HIV ART: Rapid Start
13 Apr 2023
Contributed by Lukas
In this episode, Daniel R. Kuritzkes, MD, discusses considerations for rapid initiation of antiretroviral therapy in patients who are newly diagnosed...
Perspectives From Asia on Advances in HIV Treatment and Prevention
27 Mar 2023
Contributed by Lukas
In this episode, 2 HIV experts from the Asia-Pacific region share their thoughts on some of the most important new insights from HIV treatment and pr...
RSV in Adults: How It Presents
22 Mar 2023
Contributed by Lukas
In this episode, Angela Branche, MD, and Helen Y. Chu, MD, MPH, discuss the clinical presentation of respiratory syncytial virus (RSV) in adults and t...
RSV in Adults: A Hidden Epidemic
22 Mar 2023
Contributed by Lukas
In this episode, Angela Branche, MD, and Helen Y. Chu, MD, MPH, discuss the impact of respiratory syncytial virus (RSV) and describe those at risk for...
Answering the Questions on Optimizing Antiretroviral Therapy in Heavily Treatment–Experienced People With HIV: José R. Arribas and Melissa Badowski
21 Mar 2023
Contributed by Lukas
In this episode, José R. Arribas, MD, and Melissa Badowski, PharmD, MPH, FIDSA, FCCP, BCIDP, BCPS, AAHIVP, discuss optimizing antiretroviral therapy ...
Answering the Questions on HIV PrEP Persistence
16 Mar 2023
Contributed by Lukas
In this episode, Darrell H. S. Tan, MD, FRCPC, PhD, and Kenric Ware, PharmD, AAHIVP, discuss considerations for HIV pre-exposure prophylaxis (PrEP) pe...
Answering Questions on Which HIV PrEP for Which Patient: Carolyn Chu and Samantha Strong
15 Mar 2023
Contributed by Lukas
In this episode, Carolyn Chu, MD, MSc, FAAFP, AAHIVS, and Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, answer questions including:Strategies to impr...
Hepatitis Delta in Focus: Episode 1 of Answering the Questions on Screening, Diagnosis, and Treatment
08 Mar 2023
Contributed by Lukas
In this episode, Maria Buti, MD, and Richard H. Davis, PA-C, address key considerations when screening, diagnosing, and treating patients with hepatit...
Barriers to HIV PrEP: Addressing Intersectionality
06 Mar 2023
Contributed by Lukas
In this episode, Latesha Elopre, MD, MSPH, discusses key considerations to barriers to PrEP uptake, including:Addressing disparities among racial and ...
Long-Acting PrEP: Monitoring for New HIV Infection
03 Mar 2023
Contributed by Lukas
In this episode, Darcey Wooten, MD, discusses updated guidance and rationale for monitoring for new HIV infections in people receiving long-acting Pr...
Long-Acting ART: Lenacapavir
03 Mar 2023
Contributed by Lukas
In this episode, Darcey Wooten, MD, discusses the long-acting HIV treatment agent lenacapavir for treatment-experienced people with HIV, including:Ef...
Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals
23 Feb 2023
Contributed by Lukas
In this episode, Jill Blumenthal, MD, MAS, and William R. Short, MD, MPH, AAHIVS, address key considerations when evaluating ART safety and tolerabili...
How to Screen for Hepatitis Delta Virus
23 Feb 2023
Contributed by Lukas
In this episode, Coleman I. Smith, MD, and Lydia Tang, MBChB, discuss how to screen for hepatitis delta virus (HDV), including:Algorithm for evaluati...
Ensuring Linkage to Care for Patients Diagnosed With Hepatitis Delta Virus
23 Feb 2023
Contributed by Lukas
In this episode, Nancy Reau, MD, and Lydia Tang, MBChB, discuss how to increase linkage to care rates for persons with hepatitis D virus, including:U...
Australian Perspectives on Advances in HIV
17 Feb 2023
Contributed by Lukas
In this episode, 2 Australian HIV experts share their thoughts on some of the most important HIV insights gained during the past year in the context...
Canadian Perspectives on Advances in HIV Treatment and Prevention
17 Feb 2023
Contributed by Lukas
In this episode, Canadian HIV experts share their thoughts on some of the most important new insights from HIV treatment and prevention research over ...
Perspectives From Latin America on Advances in HIV PrEP
17 Feb 2023
Contributed by Lukas
In this episode, 2 HIV experts from Latin America share their thoughts on the current status of HIV prevention strategies in the region, including rec...
European Perspectives on Advances in HIV Treatment
17 Feb 2023
Contributed by Lukas
In this episode, 2 European HIV experts share their thoughts on some of the most important new antiretroviral therapy insights from HIV research over...
Diagnosis and Management of Patients With Long COVID
31 Jan 2023
Contributed by Lukas
In this episode, Alba Azola, MD, and Monica Verduzco-Gutierrez, MD, discuss diagnosis and management of long COVID, including: Definitions of post CO...
The Role of College Campuses in HIV PrEP Uptake
31 Jan 2023
Contributed by Lukas
In this episode, Kenric Ware, PharmD, AAHIVP, discusses the role of college campuses in HIV pre-exposure prophylaxis (PrEP) uptake for adolescents, in...
How Clinic Facilities Can Prepare for Long-Acting Injectable Antiretroviral Therapy
18 Jan 2023
Contributed by Lukas
In this episode, Eric Florence, MD, PhD, discusses how clinics can prepare for the implementation of long-acting injectable antiretroviral therapy, in...
Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities
17 Jan 2023
Contributed by Lukas
In this episode, Marta Boffito, MD, PhD, FRCP, and Jens D. Lundgren, MD, DMSc, address key considerations when evaluating antiretroviral therapy safet...
Emerging Insights on Outpatient Management of Acute COVID-19 and Long COVID in Europe
13 Jan 2023
Contributed by Lukas
In this episode, Jens D. Lundgren, MD, DMSc, and Barbara Rath, MD, PhD, HDR, discuss emerging insights on outpatient management of acute COVID-19 and...
Administration of LA ART by Community Nurses in France
05 Jan 2023
Contributed by Lukas
In this episode, Laurence Slama, MD, PhD, describes some of the ways that her clinic is attempting to make IM injections of long-acting antiretroviral...
PrEP Considerations for Transgender and Nonbinary Individuals
05 Jan 2023
Contributed by Lukas
In this episode, Jill Blumenthal, MD, MAS, discusses HIV pre-exposure prophylaxis (PrEP) considerations for transgender and nonbinary individuals, inc...
Optimizing PrEP Selection and Persistence for MSM
05 Jan 2023
Contributed by Lukas
In this episode, Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, discusses optimizing HIV pre-exposure prophylaxis (PrEP) selection and persist...
Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?
04 Jan 2023
Contributed by Lukas
Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss COVID-19 treatments and the possibility ...
What Strategies Are Most Promising for Prevention and Treatment of Long COVID in Nonhospitalized Patients?
04 Jan 2023
Contributed by Lukas
Fernando Carnavali, MD; Rasika Karnik, MS, MD; and Renslow Sherer, MD, discuss long COVID, including:Long COVID prevention strategies, including COVID...
ART Selection in Treatment-Naive PWH: Weight Gain Considerations
30 Dec 2022
Contributed by Lukas
In this episode, Princy N. Kumar, MD, FIDSA, MACP, discusses key considerations for selecting ART in treatment-naive persons with HIV. Her discussion ...
Should We Be Concerned About Viral Rebound With Antiviral Agents?
30 Dec 2022
Contributed by Lukas
Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss COVID-19 rebound, including:Prevalence o...
Selecting First-line ART in Treatment-Naive Persons With HIV
29 Dec 2022
Contributed by Lukas
In this episode, Princy N. Kumar, MD, FIDSA, MACP, discusses key considerations for selecting ART in treatment-naive persons with HIV. Her discussion...
If Treatment Supply Is Limited in Future COVID-19 Viral Peaks, How Do We Ethically Prioritize Patients for Treatment?
29 Dec 2022
Contributed by Lukas
Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss how to ethically prioritize patients for...
Promoting Meningococcal Vaccine Equity in Adolescent Patients
29 Dec 2022
Contributed by Lukas
In this episode, Tamera Coyne-Beasley, MD, MPH, discusses strategies to address barriers to improve meningococcal vaccination rates by addressing soci...
Will New COVID-19 Vaccines Affect Risk Stratification?
27 Dec 2022
Contributed by Lukas
Fernando Carnavali, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss how new COVID-19 vaccines may affect risk stratification, inclu...
The Future of Long-Acting HIV Care: What’s Still Needed
22 Dec 2022
Contributed by Lukas
In this episode, an international expert panel shares their thoughts on what will be needed from future long-acting HIV treatment and prevention st...
Improving Access and Acceptance of HIV PrEP for People Who Inject Drugs
20 Dec 2022
Contributed by Lukas
In this episode, Carolyn Chu, MD, MSc, FAAFP, AAHIVS, discusses improving HIV pre-exposure prophylaxis accessibility and availability for PWID, includ...
Answering the Questions on Monkeypox in PWH
19 Dec 2022
Contributed by Lukas
In this episode, Monica Gandhi, MD, MPH, and Chloe Orkin, MBChB, FRCP, MD, discuss considerations for monkeypox, now called mpox, in people with HIV, ...
Answering the Questions on Considering an ART Switch During Pregnancy
19 Dec 2022
Contributed by Lukas
In this episode, Annette Haberl, MD, and William R. Short, MD, MPH, AAHIVS, discuss when to consider an ART switch during pregnancy, including:Current...
Expanding Access to Long-Acting ART in Europe
19 Dec 2022
Contributed by Lukas
In this episode, Stephane De Wit, MD, PhD, discusses the benefits of long-acting antiretroviral therapy (ART) for migrant populations in Europe—and...
Whom to Screen for Hepatitis Delta Virus
15 Dec 2022
Contributed by Lukas
In this episode, Nancy Reau, MD, and Coleman I. Smith, MD, discuss the burden of undiagnosed hepatitis delta virus (HDV) infection and who should be ...
Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?
15 Dec 2022
Contributed by Lukas
When it comes to managing adults with HBV, should age factor into your treatment decision—or is it important to treat everyone, regardless of age?Li...
What Patients Want in HIV Treatment and Prevention: Africa
14 Dec 2022
Contributed by Lukas
In this episode, Winnie Sseruma and Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discuss some of the barriers to genuinely patient-centered HIV...
What Patients Want in HIV Treatment and Prevention: Malaysia
07 Dec 2022
Contributed by Lukas
In this episode, Iskandar Azwa, MBChB, and patient advocate Andrew Tan Tze Tho discuss barriers to genuinely patient-centered HIV care in Malaysia and...
Addressing ART Safety and Tolerability in Transgender Individuals
07 Dec 2022
Contributed by Lukas
In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in...
Practice-Changing Viral Hepatitis Data From AASLD 2022
06 Dec 2022
Contributed by Lukas
In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:Novel therapeutics ...
FAQs: Improving Empiric Antibiotic Regimens for HABP/VABP in the ICU
06 Dec 2022
Contributed by Lukas
In this episode, Marion Elligsen, BScPhm, MSc, RPh, ACPR; Keith S Kaye, MD, MPH; and Andrew Shorr, MD, MPH, MBA, discuss key considerations for select...
Newest Viral Hepatitis Data From AASLD 2022
06 Dec 2022
Contributed by Lukas
In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including:Hepatitis BPrevention of HBV vertical transmission w...
Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Audio Recap
05 Dec 2022
Contributed by Lukas
In this episode, Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS, discuss new HIV data presented at IDWeek and HIV Glasgow 2022, includingPre...
COVID-19 Antiviral Agents and COVID-19 Rebound
22 Nov 2022
Contributed by Lukas
In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalize...
Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap
18 Nov 2022
Contributed by Lukas
In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:COVID-19 vaccines, including omicron ...
Creative Strategies for Meningococcal Vaccine Uptake
17 Nov 2022
Contributed by Lukas
In this episode, Nneka Holder, MD, MPH, shares various strategies to improve meningococcal vaccine uptake in adolescent patients, including: Use of s...
Barriers and Solutions to Expanding PrEP Uptake: Solutions
15 Nov 2022
Contributed by Lukas
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive ...
Barriers and Solutions to Expanding PrEP Uptake: Transgender Women
15 Nov 2022
Contributed by Lukas
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive ...
Barriers and Solutions to Expanding PrEP Uptake: People Who Inject Drugs
15 Nov 2022
Contributed by Lukas
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive ...
Barriers and Solutions to Expanding PrEP Uptake: Cisgender Women
15 Nov 2022
Contributed by Lukas
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive ...
Barriers and Solutions to Expanding PrEP Uptake: PrEP Inequities by Race
14 Nov 2022
Contributed by Lukas
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive ...
Cutting-Edge Concepts in HIV Care: PrEP
14 Nov 2022
Contributed by Lukas
In this episode, Paul E. Sax, MD, discusses the latest recommendations and options for HIV pre-exposure prophylaxis (PrEP), including:CDC PrEP guideli...
Cutting-Edge Concepts in HIV Care: Long-Acting Therapies
14 Nov 2022
Contributed by Lukas
In this episode, Paul E. Sax, MD, discusses long-acting (LA) injectables for HIV treatment, including: Guidance on the use of LA cabotegravir (CAB) +...
Linkage to Care After HBV Diagnosis in Asian Communities in the US
14 Nov 2022
Contributed by Lukas
This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the U...
Ending the HIV Epidemic: Persistence on ART
14 Nov 2022
Contributed by Lukas
In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discusses strategies for and importance of HIV care engagement and reengagemen...
Treatment Barriers in Asian Communities in the US
14 Nov 2022
Contributed by Lukas
This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the U...
HBV Treatment and Retention in Care Among African Communities in the US
14 Nov 2022
Contributed by Lukas
Patient advocate Bright Ansah shares some issues he encountered while seeking treatment after his diagnosis with HBV, including limited follow-up on l...
HBV Screening and Diagnosis Among African Communities in the US
14 Nov 2022
Contributed by Lukas
Listen as patient advocate William Amiteye uses his own experience as a Tanzanian immigrant to discuss important barriers to effective HBV screening a...
Barriers and Solutions to Expanding PrEP Uptake: Adolescents
07 Nov 2022
Contributed by Lukas
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive ...
If RSV Vaccines Are Approved for Older Adults, What’s Next?
02 Nov 2022
Contributed by Lukas
An RSV vaccine, if approved, may reduce disease burden in older adults. In this recap of the most common questions from a symposium at the Family Medi...
ART Safety Considerations in Aging Patients With HIV
02 Nov 2022
Contributed by Lukas
In this episode, hear Marta Boffito, MD, PhD, FRCP, and Julian Falutz, MD, FRCPC, discuss their approach to minimizing antiretroviral (ARV)-related in...
What Patients Want in HIV Treatment and Prevention: United Kingdom
02 Nov 2022
Contributed by Lukas
In this episode, Marc Thompson and Tristan J. Barber, MA, MD, FRCP, discuss some of the barriers to genuinely patient-centered HIV care in the United ...
What Patients Want in HIV Treatment and Prevention: United States
01 Nov 2022
Contributed by Lukas
In this episode, Deondre Moore and Samantha V. Hill, MD, MPH, discuss some of the barriers to genuinely patient-centered HIV care in the United State...
Addressing Barriers to PrEP Uptake Among Black Cisgender Women
31 Oct 2022
Contributed by Lukas
In this episode, Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, discusses closing the HIV pre-exposure prophylaxis (PrEP) gap for Black cisgender wome...
Addressing Barriers to PrEP Uptake Among Black MSM
27 Oct 2022
Contributed by Lukas
In this episode, Latesha Elopre, MD, MSPH, discusses closing the HIV pre-exposure prophylaxis (PrEP) gap for Black men who have sex with men (MSM), in...
London Perspective: Comorbidity and Adherence Considerations in Older Patients With HBV
27 Oct 2022
Contributed by Lukas
When it comes to managing older adults with hepatitis B virus (HBV), what comorbidity, comedication, and adherence issues should be considered?Listen ...
Switching ART in a Virologically Suppressed Person With Suspected Underlying Resistance
20 Oct 2022
Contributed by Lukas
In this episode, Timothy J. Wilkin, MD, MPH, provides a case-based overview of switching antiretroviral therapy in a patient with viral suppression on...
Answering the Questions on Switching ART With Virologic Suppression
19 Oct 2022
Contributed by Lukas
In this episode, Tristan J. Barber, MA, MD, FRCP, and Darcy Wooten, MD, discuss switching ART with virologic suppression, including:Switching with pri...
All Eyes on ExPEC: A Major Driver of Invasive Disease and Antimicrobial Resistance
18 Oct 2022
Contributed by Lukas
In this episode, Lilian Abbo, MD, FIDSA; Julie Ann Justo, PharmD, MS; and David van Duin, MD, PhD, FIDSA, FAST, discuss key concepts about extraintes...
Meningococcal Disease: A Deadly, Unpredictable but Preventable Disease
12 Oct 2022
Contributed by Lukas
In this podcast, Gary S. Marshall, MD, summarizes the burden of meningococcal disease and the importance of immunization, including: The unpredictabi...
Empowering Patients to “Age Healthy” With HIV
12 Oct 2022
Contributed by Lukas
In this episode, Cristina Mussini, MD, shares her approach to caring for aging patients with HIV. This includes not just focusing on their HIV, but th...
Managing Older Patients With Chronic HBV: A Global Perspective
10 Oct 2022
Contributed by Lukas
How do we define “older” in our older patients living with hepatitis B virus (HBV)? What monitoring and treatment options should be considered for...
Weight Gain and Cardiometabolic Toxicities in Patients With HIV
04 Oct 2022
Contributed by Lukas
In this episode, listen to Priscilla Y. Hsue, MD, and Jens D. Lundgren MD, DMSc, discuss the latest data about ARV-related weight gain and cardiometab...
Key HIV Studies Influencing My Practice Following AIDS 2022—Audio Redcap
04 Oct 2022
Contributed by Lukas
In this episode, Chloe Orkin, MBChB, FRCP, MD, discusses new HIV data from AIDS 2022, including:Prevention strategiesOral therapiesLA therapiesCureCOV...
Switching ART in the Context of Pregnancy
03 Oct 2022
Contributed by Lukas
In this episode, Roger Bedimo, MD, MS, FACP, discusses key considerations for switching ART in virologically suppressed patients who are pregnant or t...
My Lived Experience as a Woman Aging With HIV
29 Sep 2022
Contributed by Lukas
In this podcast, Melanie Reese, a woman aging with HIV, shares her perspectives on the added challenges faced by older women with HIV—an underserved...
Finding Our Voices: Older Women With HIV in Resource-Limited Settings
20 Sep 2022
Contributed by Lukas
In this episode, listen to Dorothy Onyango, patient and patient activist, share her views on the many barriers encountered by aging patients with HIV ...
Long-Acting Cabotegravir for HIV Prevention
08 Sep 2022
Contributed by Lukas
In this episode, an international expert panel shares their thoughts on key considerations for incorporating long-acting cabotegravir as an addition...
Piecing the Puzzle Together: Addressing Medical Challenges in Older PWH
25 Aug 2022
Contributed by Lukas
In this podcast, Jonathan Appelbaum, MD, FACP, AAHIVS, summarizes the many medical challenges faced by aging people with HIV, including:Underrepresent...
Ending the HIV Epidemic: Reaching the Undiagnosed
24 Aug 2022
Contributed by Lukas
In this episode, Babafemi Taiwo, MBBS, discusses strategies for reaching people with HIV who are not yet diagnosed. His overview includes:HIV diagnosi...
Ending the HIV Epidemic: Care Pathways After HIV Testing
24 Aug 2022
Contributed by Lukas
In this episode, Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD, discusses the importance of linking people to care after a positive HIV diagnosis. His o...
Ending the HIV Epidemic: Keys to Successful Treatment Initiation
24 Aug 2022
Contributed by Lukas
In this episode, Chloe Orkin, MBChB, FRCP, MD, discusses strategies for successful antiretroviral therapy (ART) initiation. Her overview includes:R...
Safety Considerations for HIV Treatments During Pregnancy
23 Aug 2022
Contributed by Lukas
In this episode, hear Dr. Jean Rene Anderson and Dr. William Short discuss special factors to consider when selecting HIV treatments during pregnancy...
Linkage to Care for Patients With HDV
03 Aug 2022
Contributed by Lukas
You can think of the “D” in HDV as standing for difficult, disadvantaged, and dangerous. Hepatitis delta virus (HDV) is difficult to diagnose, is ...
Implementing Long-Acting Cabotegravir Plus Rilpivirine for HIV Treatment: System-Level Considerations
02 Aug 2022
Contributed by Lukas
In this episode, an international expert panel shares their thoughts on key considerations at the operational level for incorporating long-acting inje...
Switching to Long-Acting Cabotegravir Plus Rilpirivine for HIV Treatment: Assessing Candidacy and Patient Counseling
14 Jul 2022
Contributed by Lukas
In this episode, an international expert panel shares their thoughts on key steps for switching patients to long-acting injectable cabotegravir plus...